Understanding the AD-Detect, Beta-Amyloid 42/40 Ratio Test
This test measures the ratio of beta-amyloid 42 to beta-amyloid 40 in plasma. It’s a significant marker for Alzheimer’s Disease, providing insights into the pathological processes occurring in the brain.
Why This Test Matters
In both conventional and functional medicine, monitoring the levels of beta-amyloid peptides is crucial. It helps in the early detection of Alzheimer’s, allowing for timely intervention and management strategies to slow down the progression of the disease.
Why Consider This Test?
Early detection is key in managing Alzheimer’s Disease. This test offers a non-invasive way to assess risk and could be a valuable tool for those concerned about Alzheimer’s, either due to family history or early symptoms.
Labs Included in Your Order
| Test Name | Reference Range | Description |
|---|---|---|
| Quest AD-Detect, Beta-Amyloid 42/40 Ratio, Plasma | Specific reference ranges are not provided as this is a relatively new test and ranges can vary based on the assay method and patient population. | Measures the ratio of beta-amyloid 42 to beta-amyloid 40, aiding in assessing Alzheimer’s Disease risk. |
According to Alzheimer’s Association, “Research has shown that the beta-amyloid 42/40 ratio may change years before the onset of Alzheimer’s symptoms, making it a potential biomarker for early detection.”
FAQs About the Test:
[rank_math_rich_snippet id=”s-a97cf09e-582a-49c6-995c-534a98c8e13b”]
References
Medical Review Board
Reviewed by Jeff Donohue M.D. from Body Logic and Brady Hurst DC, CCCN. Written by True Health Lab’s team of editorial health contributors.
Disclaimer: This information is for educational purposes only and not intended as medical advice. Consult your healthcare provider for personalized guidance.
Why Customers Trust True Health Labs - What People are saying
Also rated 4.6 out of 5 based on 3452 ShopperApproved reviews- See all TrueHealthLabs.com reviews.
